Recent progresses in deep brain stimulation of subthalamic nucleus on Parkinson′s disease and its related depression

doi:10.3969/j.issn.1674-8115.2021.06.019

Abstract

Abstract:

Depression is a common non-motor symptom of Parkinson′s disease (PD) and is a critical factor in the reduction of life quality of PD patients. The therapeutic effect of subthalamic nucleus deep brain stimulation (STN-DBS) on PD motor symptoms has been well documented. However, their effect on the related depression in PD is inconclusive. This article reviews the epidemiological characteristics and pathogenesis of PD and its related depression, the mechanism underlying the effects of STN-DBS on PD-related depression, the imaging and electrophysiological research of STN-DBS on PD and its related depression, the effects of STN-DBS on drug use, and the effects of electrode position on emotion.

Key words: Parkinson′s disease (PD), depression, subthalamic nucleus, deep brain stimulation

CLC Number:

R742.5

Xiao-xiao ZHANG, Chen-cheng ZHANG, Yi-jie LAI, Bo-min SUN. Recent progresses in deep brain stimulation of subthalamic nucleus on Parkinson′s disease and its related depression[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 815-820.

TrendMD

References 64

1	Armstrong MJ, Okun MS. Diagnosis and treatment of parkinson disease: a review[J]. JAMA, 2020, 323(6): 548-560.
2	Dobkin RD, Menza M, Allen LA, et al. Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial[J]. Am J Psychiatry, 2011, 168(10): 1066-1074.
3	Luquin MR, Kulisevsky J, Martinez-Martin P, et al. Consensus on the definition of advanced Parkinson's disease: a neurologists-based Delphi study (CEPA study)[J]. Parkinsons Dis, 2017, 2017: 4047392.
4	Kuhlman GD, Flanigan JL, Sperling SA, et al. Predictors of health-related quality of life in Parkinson's disease[J]. Park Relat Disord, 2019, 65: 86-90.
5	Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes[J]. Mov Disord, 2006, 21(): S290-S304.
6	Combs HL, Folley BS, Berry DT, et al. Cognition and depression following deep brain stimulation of the subthalamic nucleus and globus pallidus pars internus in Parkinson's disease: a meta-analysis[J]. Neuropsychol Rev, 2015, 25(4): 439-454.
7	Abbes M, Lhommée E, Thobois S, et al. Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study[J]. J Neurol Neurosurg Psychiatry, 2018, 89(8): 836-843.
8	Lhommée E, Klinger H, Thobois S, et al. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours[J]. Brain, 2012, 135(Pt 5): 1463-1477.
9	Lilleeng B, Gjerstad M, Baardsen R, et al. The long-term development of non-motor problems after STN-DBS[J]. Acta Neurol Scand, 2015, 132(4): 251-258.
10	Reijnders JS, Ehrt U, Weber WE, et al. A systematic review of prevalence studies of depression in Parkinson's disease[J]. Mov Disord, 2008, 23(2): 183-189;quiz313.
11	Chagas MH, Moriyama TS, Felício AC, et al. Depression increases in patients with Parkinson's disease according to the increasing severity of the cognitive impairment[J]. Arq Neuropsiquiatr, 2014, 72(6): 426-429.
12	Shen CC, Tsai SJ, Perng CL, et al. Risk of Parkinson disease after depression: a nationwide population-based study[J]. Neurology, 2013, 81(17): 1538-1544.
13	Mayberg HS, Solomon DH. Depression in Parkinson's disease: a biochemical and organic viewpoint[J]. Adv Neurol, 1995, 65: 49-60.
14	Ossowska K, Lorenc-Koci E. Depression in Parkinson's disease[J]. Pharmacol Rep, 2013, 65(6): 1545-1557.
15	Arabia G, Grossardt BR, Geda YE, et al. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease[J]. Arch Gen Psychiatry, 2007, 64(12): 1385-1392.
16	Wang JY, Fan QY, He JH, et al. SLC6A4 repeat and single-nucleotide polymorphisms are associated with depression and rest tremor in Parkinson's disease: an exploratory study[J]. Front Neurol, 2019, 10: 333.
17	Meloni M, Puligheddu M, Carta M, et al. Efficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson's disease: a preliminary finding[J]. Eur J Neurol, 2020, 27(5): 779-786.
18	Braak H, Ghebremedhin E, Rüb U, et al. Stages in the development of Parkinson's disease-related pathology[J]. Cell Tissue Res, 2004, 318(1): 121-134.
19	Kostić VS, Agosta F, Petrović I, et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease[J]. Neurology, 2010, 75(10): 857-863.
20	Aarsland D, Påhlhagen S, Ballard CG, et al. Depression in Parkinson disease: epidemiology, mechanisms and management[J]. Nat Rev Neurol, 2011, 8(1): 35-47.
21	Odekerken VJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial[J]. Lancet Neurol, 2013, 12(1): 37-44.
22	Zhou HY, Wang LB, Zhang CC, et al. Acute effects of subthalamic deep brain stimulation on motor outcomes in Parkinson's disease; 13 year follow up[J]. Front Neurol, 2019, 10: 689.
23	Chopra A, Abulseoud OA, Sampson S, et al. Mood stability in Parkinson disease following deep brain stimulation: a 6-month prospective follow-up study[J]. Psychosomatics, 2014, 55(5): 478-484.
24	Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 2004, 75(6): 834-839.
25	McDonald LM, Page D, Wilkinson L, et al. Deep brain stimulation of the subthalamic nucleus improves sense of well-being in Parkinson's disease[J]. Mov Disord, 2012, 27(3): 372-378.
26	Fabbri M, Coelho M, Guedes LC, et al. Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease[J]. Parkinsonism Relat Disord, 2017, 41: 113-117.
27	Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation[J]. N Engl J Med, 1999, 340(19): 1476-1480.
28	Doshi PK, Chhaya N, Bhatt MH. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease[J]. Mov Disord, 2002, 17(5): 1084-1085.
29	Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial[J]. Ann Neurol, 2009, 65(5): 586-595.
30	Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease[J]. N Engl J Med, 2010, 362(22): 2077-2091.
31	Berney A, Vingerhoets F, Perrin A, et al. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients[J]. Neurology, 2002, 59(9): 1427-1429.
32	Houeto JL, Mesnage V, Mallet L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation[J]. J Neurol Neurosurg Psychiatry, 2002, 72(6): 701-707.
33	Strutt AM, Simpson R, Jankovic J, et al. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease[J]. Eur J Neurol, 2012, 19(1): 121-127.
34	Petersson P, Halje P, Cenci MA. Significance and translational value of high-frequency cortico-basal Ganglia oscillations in Parkinson's disease[J]. J Parkinsons Dis, 2019, 9(1): 183-196.
35	Karachi C, Yelnik J, Tandé D, et al. The pallidosubthalamic projection: an anatomical substrate for nonmotor functions of the subthalamic nucleus in Primates[J]. Mov Disord, 2005, 20(2): 172-180.
36	Hilker R, Voges J, Weisenbach S, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease[J]. J Cereb Blood Flow Metab, 2004, 24(1): 7-16.
37	Temel Y, Blokland A, Steinbusch HW, et al. The functional role of the subthalamic nucleus in cognitive and limbic circuits[J]. Prog Neurobiol, 2005, 76(6): 393-413.
38	Rodriguez-Oroz MC, Gorospe A, Guridi J, et al. Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease[J]. Neurology, 2000, 55(12 ): S45-S51.
39	Kim HJ, Jeon BS, Paek SH. Nonmotor symptoms and subthalamic deep brain stimulation in Parkinson's disease[J]. J Mov Disord, 2015, 8(2): 83-91.
40	Politis M, Wu K, Loane C, et al. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study[J]. Neurobiol Dis, 2010, 40(1): 216-221.
41	Tan SK, Hartung H, Sharp T, et al. Serotonin-dependent depression in Parkinson's disease: a role for the subthalamic nucleus?[J]. Neuropharmacology, 2011, 61(3): 387-399.
42	Navailles S, Benazzouz A, Bioulac B, et al. High-frequency stimulation of the subthalamic nucleus and L-3, 4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and Hippocampus in a rat model of Parkinson's disease[J]. J Neurosci, 2010, 30(6): 2356-2364.
43	Stefani A, Cerroni R, Mazzone P, et al. Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: central role of disease severity[J]. Eur J Neurosci, 2019, 49(6): 805-816.
44	Kumar R, Lozano AM, Sime E, et al. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation[J]. Neurology, 1999, 53(3): 561-566.
45	Cummings JL. Frontal-subcortical circuits and human behavior[J]. Arch Neurol, 1993, 50(8): 873-880.
46	Klauser P, Fornito A, Lorenzetti V, et al. Cortico-limbic network abnormalities in individuals with current and past major depressive disorder[J]. J Affect Disord, 2015, 173: 45-52.
47	Feldmann A, Illes Z, Kosztolanyi P, et al. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study[J]. Mov Disord, 2008, 23(1): 42-46.
48	Cardoso EF, Maia FM, Fregni F, et al. Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus[J]. Neuroimage, 2009, 47(2): 467-472.
49	Jeune F, Péron J, Grandjean D, et al. Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study[J]. Eur J Nucl Med Mol Imaging, 2010, 37(8): 1512-1520.
50	Kalbe E, Voges J, Weber T, et al. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease[J]. Neurology, 2009, 72(1): 42-49.
51	Langner-Lemercier S, Drapier S, Naudet F, et al. Preoperative brain metabolism and quality of life after subthalamic nucleus stimulation in Parkinson's disease[J]. J Neurol, 2015, 262(4): 881-889.
52	Rappel P, Grosberg S, Arkadir D, et al. Theta-alpha oscillations characterize emotional subregion in the human ventral subthalamic nucleus[J]. Mov Disord, 2020, 35(2): 337-343.
53	Kühn AA, Hariz MI, Silberstein P, et al. Activation of the subthalamic region during emotional processing in Parkinson disease[J]. Neurology, 2005, 65(5): 707-713.
54	Thobois S, Ardouin C, Lhommée E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation[J]. Brain, 2010, 133(Pt 4): 1111-1127.
55	Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease[J]. Brain, 2008, 131(Pt 10): 2720-2728.
56	Alexoudi A, Shalash A, Knudsen K, et al. The medical treatment of patients with Parkinson's disease receiving subthalamic neurostimulation[J]. Parkinsonism Relat Disord, 2015, 21(6): 555-560.
57	Zibetti M, Cinquepalmi A, Angrisano S, et al. Management of antiparkinsonian therapy during chronic subthalamic stimulation in Parkinson's disease[J]. Parkinsonism Relat Disord, 2009, 15(): S76-S80.
58	Yu XX, Fernandez HH. Dopamine agonist withdrawal syndrome: a comprehensive review[J]. J Neurol Sci, 2017, 374: 53-55.
59	Brunenberg EJ, Moeskops P, Backes WH, et al. Structural and resting state functional connectivity of the subthalamic nucleus: identification of motor STN parts and the hyperdirect pathway[J]. PLoS One, 2012, 7(6): e39061.
60	Dafsari HS, Petry-Schmelzer JN, Ray-Chaudhuri K, et al. Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts[J]. Brain Stimul, 2018, 11(4): 904-912.
61	Krack P, Hariz MI, Baunez C, et al. Deep brain stimulation: from neurology to psychiatry?[J]. Trends Neurosci, 2010, 33(10): 474-484.
62	Blomstedt P, Hariz MI, Lees A, et al. Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report[J]. Parkinsonism Relat Disord, 2008, 14(3): 253-256.
63	Starkstein SE, Brockman S. Management of depression in Parkinson's disease: a systematic review[J]. Mov Disord Clin Pract, 2017, 4(4): 470-477.
64	苗海锋, 马荣, 吴志强, 等. 帕罗西汀治疗帕金森病伴发抑郁障碍临床疗效与安全性分析[J]. 中国实用神经疾病杂志, 2014, 17(4): 9-12.

[1]	SU Shanshan, JIANG Wenhui, WANG Shuting, XU Mizhen, REN Xueqing, QIU Jianyin. Impact of anxiety levels and alexithymia degree on the quality of life in patients with anxiety disorders [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(5): 584-590.
[2]	SUN Chenyin, WU Baichuan, ZHANG Huifeng, FANG Yiru, PENG Daihui. Evaluation of circadian rhythms in depression by using actigraphy: a systematic review and meta-analysis [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(5): 606-616.
[3]	GU Juanhua, JIAO Yang, LU Lin, WANG Linlin. Functions of SNARE complex in glial cells and its relationship with the development of depressive disorder [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(5): 653-657.
[4]	HU Canfang, ZHONG Chuanyu, CAO Li. Research progress of neuromodulation in the treatment of Parkinson's disease [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(2): 258-263.
[5]	LU Qifan, LIU Qiming, ZHOU Hongmei, CHAI Yezi, JIANG Meng, PU Jun. Effect of somatic symptoms, anxiety and depression on clinical prognosis in patients with chronic heart failure [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(9): 1153-1161.
[6]	MA Wenlin, LIN Yuanjie, JIN Tingting, SHI Wei, JIANG Lihua, ZHAO Li. Relationship between egocentrism and non-suicidal self-injury in junior high school students [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(8): 971-976.
[7]	MA CUI, YE Yujuan, YAN Xingke. Research progress on the neural circuit of pain emotion mediated by amygdala [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(10): 1304-1310.
[8]	WANG Yakun, XU Jiarui, WU Qianqian, ZHANG Xiaohua, ZHU Yingchun, BAI Shoujun. Effect of combination of medical care and nursing on the quality of life and mental state of elderly patients with chronic kidney disease in Shanghai suburbs [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(7): 904-910.
[9]	Meng-ting SHEN, Xuan-hong ZHANG, Zhen-ying QIAN, Hui LI, Jian-hua SHENG, Ji-jun WANG, Ying-ying TANG. Comparison of mismatch negativity in patients with schizophrenia and depression [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1041-1045.
[10]	Jing WU, Xue-yi LI, Jing-hong CHEN, Ze-jian WANG. Study on changes of hippocampal bile acid receptors in the depression mouse models [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(12): 1628-1634.
[11]	Bo SHI, Jian-min CHEN, Jun-xiong ZHAO, Wei TANG, Wei-xing FAN, Cheng-cheng ZHANG, Chen ZHANG. Association study of CREB1 gene with depression and bipolar disorder typeⅡ [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(10): 1303-1307.
[12]	Rui-xue YUAN, Ying-mei FU, Shun-ying YU. Research progress in the mechanism of helper T cell 17 and regulatory T cell in depression [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(10): 1384-1388.
[13]	PENG Yi-hua1, HUANG Ye2, NIE Lei-yan1, LIU Qiang1#, CHEN Jue1#. Reliability and validity of self-rated Family Burden Scale in families of the patients with anorexia nervosa [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(6): 804-808.
[14]	QIAN Shi-xing, FANG Yuan#, SUN Lin, QIU Qi, LIN Zhi-guang, XIAO Shi-fu, LI Xia#. Effect of citalopram on miRNA-16/serotonin transporter pathway in peripheral blood of patients with depression [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(6): 814-819.
[15]	NI Xue-ping1, 2, LI Xian-hua2, XIN Xiao2, WU Sheng-jia1, 2, SONG Ting1, HE Yang2, ZHENG Xin2. Current status of self-perceived burden and related factors in the patients with non-Hodgkin's lymphoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(6): 856-862.